Last updated 2026-06-18
- Acquired by Guardant Health, Feb 2026
- Raised $8M funding round, Nov 2024
- Raised funding round led by aMoon Fund, Apr 2022
Total raised
$8.0M
Last: 2024-11
Stage
Acquired
Founded
2020
Headcount
21
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences
About
MetaSight develops and deploys accurate, affordable, and accessible diagnostics for diverse diseases through a single blood test – applicable for population scale screening.
Its approach leverages the world’s largest clinico multi-OMICS database, generated using our proprietary unbiased metabolomics, lipidomics, and proteomics platform.
Funding history · 2 rounds · $8.0M total
2024-11
2022-04
Undisclosed
Q&A
- What is MetaSight Diagnostics' primary focus?
- MetaSight Diagnostics is focused on revolutionizing liquid biopsy by developing and deploying accurate, affordable, and accessible diagnostics for diverse diseases through a single blood test, applicable for population scale screening.
- When was MetaSight Diagnostics founded?
- MetaSight Diagnostics was founded in April 2020.
- What is the current status of MetaSight Diagnostics?
- MetaSight Diagnostics is currently active and was acquired by Guardant Health in February 2026.
- How many employees does MetaSight Diagnostics have?
- MetaSight Diagnostics has 11-50 employees.
- What was MetaSight Diagnostics' most recent funding round?
- In November 2024, MetaSight Diagnostics raised $8,000,000. Investors included Saban Ventures and aMoon Fund.
- What is MetaSight Diagnostics' total funding raised to date?
- MetaSight Diagnostics has raised a total of $8,000,000.
- Which sector does MetaSight Diagnostics primarily operate in?
- MetaSight Diagnostics' primary sector is Health Tech & Life Sciences.
- Where is MetaSight Diagnostics headquartered?
- MetaSight Diagnostics is headquartered in Rehovot, Israel.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & Screening
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals
Business model
B2B
Tags
spectroscopyoncologydiagnosticspharmaceuticalsbiopsybiotechnologyinflammatory-diseasesblood-testbiomarkers
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | metasightdx.com |
|---|---|
| linkedin.com/company/82976943 |
Identifiers & details
| Founded | 2020-4 |
|---|---|
| Employees (exact) | 21 |
| Status reason | Acquired by Guardant Health on Feb 2026 |
Acquisitions & public offerings
Acquired by Guardant Health 2026-02
Radar intelligence
Patents
| EPO | 2 |
|---|
Web history (Wayback)
| Domain | metasightdx.com |
|---|